Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Clinical trial NCT05379985 · RECRUITING

Trial details

NCT number: NCT05379985
Sponsor: Revolution Medicines, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)Advanced Solid Tumors

Start date: 2022-05-31
Primary completion: 2027-05-31
Enrollment: 754

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.